This agreement will serve to broaden the audience currently using BioSpace.com by directly linking our community with an industry leader like Incyte, said Scott Clarke, CEO of BioSpace.com. The information and products that Incyte provides are critical to conducting genomics experiments. Incyte is now one of over 120 suppliers offering more than 1.2 million products through the BioSpace.com marketplace.
Incyte will leverage BioSpace’s expertise in building customized business-to-business supply solutions to provide scientists worldwide with access to Incyte’s LifeSeq(R) Gene-by-Gene, LifeSeq(R) Public, and other valuable gene-based research tools and services, including clone reagents, microarrays, custom sequencing, genomic annotation, and mouse knockout services.
Through its collaboration with the National Institutes of Health, BioSpace.com has developed an innovative business-to-business supply solution. This agreement enables Incyte to broaden its customer reach by making our gene-based research tools and services available to researchers and scientists worldwide, said Roy A. Whitfield, CEO of Incyte in a company statement. By allowing researchers to link directly to our newly expanded web site, researchers are able to use our bioinformatics expertise to search LifeSeq Public or LifeSeq Gene-by-Gene, and to order clones and other products for their research needs.
